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In this study, diethylaminosulfur triﬂuoride (DAST) was successfully applied in monoﬂuorination reac-
tions of some triﬂuoromethyl substituted 2-hydroxy-2H-chromenones, employing a general, mild, and
efﬁcient methodology. The ﬂuorinated compounds (2-ﬂuoro-2H-chromenones) were synthesized as
unique products by a chemoselective reaction in 63–81% yield despite the presence of different reactive
sites subjected to reactions with DAST.
 2011 Elsevier Ltd. Open access under the Elsevier OA license.Multi-component reactions (MCRs), by virtue of their conver-
gence, productivity, facile execution, and generally high yields of
products, have attracted much attention from the vantage point
of combinatorial chemistry.
Recently obtained also by MCR’s, functionalized chromenes and
benzopyranes are an important class of compounds, which have
received considerable attention in recent years due to their wide
range of biological activities. They display not only spasmolytic,
diuretic, clotting, antiviral, anti-tumoral and anti-anaphylactic
activities, but can also be used as pigments, photo active materials,
and biodegradable agrochemicals.1
On the other hand, ﬂuorine substitution can alter the chemical
properties, disposition, and biological activity of drugs.2 Many
ﬂuorinated compounds are currently widely used in the treatment
of diseases. These include antidepressants, antiinﬂammatory
agents, antimalarial drugs, antipsychotics, antiviral agents, ste-
roids, and general anesthetics.3 The chemistry and medicinal
chemistry of ﬂuoro-organic compounds and drugs have been re-
viewed.2,4–6 The development of new ﬂuorinating agents has vastly
increased the potential for synthesis of novel ﬂuorinated drugs. In
addition, the development of sophisticated noninvasive analytical
techniques based on ﬂuorine nuclear magnetic resonance (NMR)
and positron emission topography has transformed the study of
ﬂuorinated drugs in man and animals.7
The inclusion of a ﬂuorine atom in a drug molecule can inﬂu-
ence both the disposition of the drug and the interaction of the
drug with its pharmacological target. For example, the effects of
ﬂuorine substitution on the inter- and intramolecular forces that
affect the binding of ligands, and thus introduce the receptor sub-
type selectivity, at cholinergic and adrenergic receptors are now
well understood.8x: +55 55 3220 8031.
orso).
sevier OA license.Fluorine substitution can also have a profound effect on drug
disposition, in terms of distribution, drug clearance, route(s), and
extent of drug metabolism.9 Such changes can be used construc-
tively by medicinal chemists to improve both the safety and the
efﬁcacy of a drug.
Thus, considering the importance described and based on the
works previously published by us,10,11 the aim of this work is to re-
port a facile, efﬁcient, and chemoselective ﬂuorination of 2-hydro-
xy-2H-chromenones 1 using DAST.
Commercially available diethylaminosulfur triﬂuoride (DAST)
reacts with aldehydes and ketones under mild conditions to give
geminal diﬂuorides,11 while organic acids react with DAST to give
acid ﬂuorides.12 Reaction of mono alcohols with DAST replaces
the hydroxy group13 with ﬂuorine while reaction with diols allows
isolation of diﬂuorides, sulﬁte esters, or cyclic ethers.14 In addition,
reactions of propargylic ketones and acetophenone in the presence
of 2 equiv of DAST furnished gem-diﬂuoro derivatives.15 a,b-Unsat-
urated ketones, such as 2(1H)-naphthalenones were converted also
to gem-diﬂuoro-naphathalenes by dehydroxy-ﬂuorination using
DAST.16 Recently, a ring enlargement and contraction17 as well as
cyclization reactions of a-acylaminoketones18 promoted by DAST
were described.
Thus, considering the wide reactivity of DAST, we initially exam-
ined several possibilities of reaction in 2-hydroxy-2H-chromenones
(1a–e), previously synthesized by us,19 since there are different
reactive sites present in these compounds (one hydroxyl and two
carbonyl groups), offering the possibility to obtain different prod-
ucts, such as di- or monoﬂuorinated, dehydrated products among
others. Moreover, because of the two enolization possibilities
(Fig. 1) of the ketone function at the C-5, and at the aroyl substituent
attached to the C-3, the alternative dehydroxy-ﬂuorinations cannot
be ruled out.15,16
In an attempt to evaluate the behavior of 2-hydroxy-2H-
chromenones (1a–e) in the presence of DAST, we initially carried
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Figure 1. Tautomeric forms of chromenones 1.
3334 H. G. Bonacorso et al. / Tetrahedron Letters 52 (2011) 3333–3335out reactions employing DAST in a 1:2 molar ratio (excess of the
DAST), in dichloromethane as a solvent, for 24 h at room tempera-
ture (Scheme 1).20 These reactions demonstrated that only a mono-
ﬂuorination reaction in the 2 position occurred (2a–e) with 100%
chemoselectivity and no other product was obtained. The products
2a–ewere easily isolated as solids by ﬁltration and puriﬁed by sim-
ple washing with cold ethanol, in good yields.21
With the goal of also promoting the diﬂuorination reaction on
the carbonyl functions present, we carried out reactions employing
DAST in different molar ratios (1:3, 1:4 and 1:5), in dichlorometh-
ane as solvent, for 24, 36, and 48 h, at room temperature. However,
under any condition, again only the ﬂuorination reaction in the 2
position was observed (2a–e) and the presence of the diﬂuorinated
or dehydrated compounds was not observed.Figure 2. A perspective view of 2-ﬂuoro-3-(4-ﬂuorobenzoyl)-4-phenyl-2-(triﬂuorome
794627).22 Displacement ellipsoids are drawn at 50% probability level.Compounds 2 are constituted by a 3,4,7,8-tetrahydro- 2H-chro-
men-5(6H)-one ring which is the core of the structure and it has
four main substituents attached: a ﬂuorine and a triﬂuoromethyl
group at the C2-position and an acyl and an aryl substituent at
the C3- and C4-positions, respectively. The structures of com-
pounds 2 were fully conﬁrmed by 1H NMR, 13C NMR, 19F NMR,
MS with chemical ionization, in the positive mode (CI+), and ele-
mental analysis.21
Thus, for example, compound 2b, obtained as a yellow solid,
showeda [M+1] ionpeak atm/z437 in themass spectrum, according
to themolecular formulaC23H17F5O3. 1HNMRspectra showed theH-
3 at d 4.5 ppm as a doublet (J = 6 Hz), characterizing the coupling
with ﬂuorine atom. The H-4 of the chromenone appeared at d 4.0
ppm as one singlet peak. Due to the presence of the ﬂuorine and athyl)- 3,4,7,8-tetra-hydro-2H-chromen-5(6H)-one (2b) with atoms labeled (CCDC
H. G. Bonacorso et al. / Tetrahedron Letters 52 (2011) 3333–3335 3335CF3 group in the C-2 position, compounds 2 presented characteristic
13C chemical shifts. The C-2 exhibited signals at d 103.7 ppm, as a
characteristic doublet of quartet, with 1JCF = 236 Hz, 2JCCF = 36 Hz,
due to the attachment to a ﬂuorine and a CF3 group. The CF3 group
showed a signal at d 118.6 ppm, as a quartet of doublet, with
1JCF = 286 Hz; 2JCCF = 36 Hz. Unexpectedly and with the exception
for 2a (Ar = R), the 19F NMR spectra for 2b–e (Ar– R) showed two
singlets for the ﬂuorine atom attached to the C-2 and one singlet
for the CF3 group bonded to the same carbon (C-2). Complementa-
rily, the X-ray diffraction measurement was carried out for com-
pound 2b (Fig. 2)22 proving that the ﬂuorine atom replaced the
hydroxyl group in the 2 position. In addition, this paper conﬁrmed
what had been suggested byArbilla et al.23 The author proposed that
themechanismbywhich the reaction occurredwithDAST should be
an SN2 type. This fact was conﬁrmed by us as wewatched the inver-
sion of conﬁguration at C-2 in comparison to the spectroscopy and
X-ray diffraction data for the precursors 1.19
In the present Letter, we have demonstrated that using a
mild and an efﬁcient protocol for the chemoselective ﬂuorina-
tion reaction of the 2-hydroxy-tetrahydro-2H-chromenones by
DAST in CH2Cl2 at 0–25 C for 24 h, 2-ﬂuoro-2H-chromenones
can be easily obtained in good yields (63–81%) and as a unique
product, because no side reaction products were observed or
isolated.
Unless otherwise indicated all common reagents and solvents
were used as obtained from commercial suppliers without further
puriﬁcation. All melting points were determined on a Reichert
Thermovar apparatus. 1H, 13C and 19F NMR spectra were acquired
on a Bruker DPX 200 spectrometer (1H at 200.13 MHz) and Bruker
DPX 400 (13C at 100.32 MHz and 19F at 376.3 MHz) spectrometer,
5 mm sample tubes, 298 K, digital resolution ±0.01 ppm, in CDCl3,
using TMS as internal reference (1H and 13C) or ﬂuorobenzene as
external reference (19F). The CHN elemental analyses were per-
formed on a Perkin Elmer 2400 CHN elemental analyzer (São Pau-
lo University–USP/Brazil). Mass spectra were registered in a HP
5973 MSD connected to a HP 6890 GC and interfaced by a
Pentium PC. The GC was equipped with a split-splitless injector,
autosampler, cross-linked HP-5 capillary column (30 m,
0.32 mm of internal diameter), and He was used as the carrier
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